Therapeutic Progress in Ovarian Cancer, Testicular Cancer and the Sarcomas: Boerhaave Series for Postgraduate Medical Education, cartea 16
Editat de A. van Oosterom, Franco M. Muggia, F.J. Cletonen Limba Engleză Paperback – 10 noi 2011
Din seria Boerhaave Series for Postgraduate Medical Education
- Preț: 382.95 lei
- 5% Preț: 374.78 lei
- 5% Preț: 368.00 lei
- 5% Preț: 361.42 lei
- 5% Preț: 371.47 lei
- 5% Preț: 712.09 lei
- 5% Preț: 365.10 lei
- 5% Preț: 368.37 lei
- 5% Preț: 381.35 lei
- 5% Preț: 368.93 lei
- 5% Preț: 371.83 lei
- 5% Preț: 361.42 lei
- 5% Preț: 364.74 lei
- 5% Preț: 366.56 lei
- 5% Preț: 364.74 lei
- 5% Preț: 366.70 lei
- 5% Preț: 376.95 lei
- 5% Preț: 363.60 lei
- 5% Preț: 371.66 lei
- 5% Preț: 360.86 lei
- 5% Preț: 365.99 lei
- 5% Preț: 366.19 lei
Preț: 381.35 lei
Preț vechi: 401.42 lei
-5% Nou
Puncte Express: 572
Preț estimativ în valută:
72.98€ • 76.10$ • 60.65£
72.98€ • 76.10$ • 60.65£
Carte tipărită la comandă
Livrare economică 21 martie-04 aprilie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9789400991552
ISBN-10: 940099155X
Pagini: 528
Ilustrații: 516 p.
Dimensiuni: 155 x 235 x 28 mm
Greutate: 0.73 kg
Ediția:Softcover reprint of the original 1st ed. 1980
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Boerhaave Series for Postgraduate Medical Education
Locul publicării:Dordrecht, Netherlands
ISBN-10: 940099155X
Pagini: 528
Ilustrații: 516 p.
Dimensiuni: 155 x 235 x 28 mm
Greutate: 0.73 kg
Ediția:Softcover reprint of the original 1st ed. 1980
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Boerhaave Series for Postgraduate Medical Education
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
One: Ovarian Cancer.- 1. Cytoreductive surgical treatment in the management of advanced ovarian cancer.- 2. Post-operative radiotherapy in ovarian cancer stages I and II.- 3. Radiotherapy in the treatment of stages III and IV.- 4. Cisplatin therapy of ovarian cancer.- 5. Hexamethylmelamine and cisplatinum combinations in the treatment of ovarian cancer.- 6. Current treatment and new prospects.- 7. Second-look laparotomy and prognosis related to extent of residual disease.- 8. Long term survival following chemotherapy for advanced epithelial ovarian carcinoma.- 9. New drugs in ovarian cancer: in vitro. Phase II screening with the human tumor stem cell assay.- 10. New drugs in the treatment of ovarian cancer.- 11. Current and future management of ovarian cancer Paneldi scussion: Chairman.- Two: Testicular Cancer.- 12. Role of surgery in the management of nonsemino- matous germ cell tumors of the testis.- 13. Role of radiotherapy in the treatment of testicular cancer.- 14. Combination of chemotherapy and radiotherapy in the treatment of testicular cancer.- 15. Testicular cancer: The Indiana University experience.- 16. The VAB schemes of treatment for germ cell tumors.- 17. Combination of chemotherapy and debulking surgery.- 18. New leads from the laboratory for treating testicular cancer.- 19. New drugs in the treatment of testicular cancer.- 20. An update of the Dutch Multicenter PVB-study in disseminated testicular nonseminomas.- 21. Chemotherapy of advanced malignant teratomas.- 22. Current and future management of testicular cancer Paneldi scussion: Chairman.- Three : Osteosarcoma.- 23. Classification and prognosis of osteosarcoma.- 24. Surgery and adjuvant chemo-immunotherapy in osteosarcoma: Review of treatment at the National Cancer Institute.- 25. The role of radiotherapy in the treatment of the primary and in adjuvant therapy.- 26. Chemotherapy of osteosarcoma — An overview.- 27. The succesful management of metastatic osteogenic sarcoma: A model for the treatment of primary osteogenic sarcoma.- 28. Current and future management of osteosarcoma Paneldiscussion : Chairman.- Four: Soft Tissue Sarcoma.- 29. Soft tissue sarcoma — Classification and prognosis.- 30. Surgery and adjuvant radiation-chemo-immunotherapy in soft tissue sarcomas: Results of treatment at the National Cancer Institute.- 31. Soft tissue sarcoma: Treatment of advanced disease in the Royal Marsden Hospital.- 32. Treatment of advanced soft tissue sarcomas in adults: Past, present, and future.- 33. Treatment of childhood soft tissue sarcomas.- 34. New drugs for the treatment of soft tissue sarcomas.- 35. Current and future management of soft tissue sarcoma Paneldiscussion: Chairman.